Symposia: ARTERIALE 2020 – the circle from target organ damage to clinical event « Българска Лига по Хипертония

Symposia: ARTERIALE 2020 – the circle from target organ damage to clinical event

blh-info

Symposia: ARTERIALE 2020 – the circle from target organ damage to clinical event

The event is included in the list of scientific forums approved by the European Society of Hypertension

31 Jan – 02 Feb 2020

Sofia Tech Park, John Atanassov Innovation forum, Sofia, Bulgaria

Friday, 31.01.2020

Educational module “Cognitive impairment in patients with cardiovascular risk factors“ – preliminary seminary of

the scientific program ARTERIALE 2020, supported by ACTAVIS

Hour	Hall А	Hall B
09:00 – 13:00		Educational module “Cognitive impairment in patients with cardiovascular risk factors“ Supported by ACTAVIS Moderators: Acad. Prof. Lachezar Traykov, and Prof. Arman Postagyan
09:00-09:20		The role of arterial pressure for the cognitive function Dr. Teodora Yaneva
09:20-09:40		Hypertension and brain. Prevention and treatment combinations Prof. Ivan Gruev
09:40-10:00		Dyslipidemia and the brain Prof. Arman Postagyan
10:00-10:20		Brain and function (cognitive disorders) – is early diagnosis early enough? Acad. Prof. Lachezar Traykov
10:20-10:30		Discussion
10:30-11:00	Coffee pause	Coffee pause
11:00-11:30		Early neuropsychological diagnosis. Practical applications of the new diagnostic criteria and procedures Ass. Prof. Margarita Raycheva
11:30-11:50		How to use the diagnostic criteria and procedures – clinical cases illustration Acad. Prof. Lachezar Traykov, Ass. Prof. Margarita Raycheva
11:50-12:10		How the assessment of vascular function contribute to the management in practice – clinical cases illustration Prof. Arman Postagyan, Prof. Ivan Gruev, Dr. Teodora Yaneva
12:10-12:40		Vascular risk factors and opportunity for neuroprotection in the practice Acad. Prof. Lachezar Traykov
12:40-13:00		Discussion

Hour	Hall A	Hall B
12:50-13:00	Opening address
13:00-13:30	Session: Arterial Hypertension and comorbidities – focus on dislipidemia What DLP patients benefit the most from effective LLT – the definition of extremely high risk patients Prof M. Banach
13:30-14:00	Montavit symposium: Role of nutraceutics in the complex management of dyslipidemia Prof. A. Postagyan
14:00-15:30	Session: Challenges in the diagnosis and management of arterial hypertension Moderators – Prof D. Raev, Prof. S. Tisheva Preclinical forms of hypertension Prof. F. Nikolov Ambulatory blood pressure and target organ damage Prof. D. Raev Orthostatic Intolerance – diagnostic algorithm and relevance to clinical practice Acad. Prof. Е. Tityanova Orthostatic hypo- and hypertension – clinical challenges Ass. Prof.. N. Stancheva	Session: Arterial hypertension and obesity Moderators – Ass. Prof. E. Манов, Dr. Т. Yaneva Arterial hypertension and obesity Ass. Prof. E. Манов Prediabetes and cardiovascular risk Dr. A.Gateva Obesity and extreme obesity – from myocardial metabolism to left ventricular kinetics Dr. Sv. Tzonev
15:30 – 15:50	Coffee pause	Coffee pause
15:50 – 16:30	Novo Nordisk symposium: Release the potential in the treatment of type 2 diabetes mellitus Prof. Tz. Tankova Dr. G. Grozeva
16:30 – 18:00	Session: From target organ damage to a clinically overt disease – focus on heart failure (with the support of Polpharma) Moderators: Prof. F. Nikolov, Prof. Y. Yotov Myocardial Ischemia – the link between Hypertension and Heart Failure Prof. M. Dorobantu Arterial hypertension therapy optimization and heart failure RAAS blockers Dr. L. Mircheva Beta-blockers Ass. Prof. P. Petrovski МРА Prof.A. Postagyan The route of the heart failure patient – dilemmas on the provision of continuous, optimal care for patients with heart failure Prof. Y. Yotov	Session: Assessment of the hypertensive organ damage – what options do we have Moderators: Prof. Gruev, Ass. Prof. Naydenov Assessment of the involvement of great vessels Prof. M. Staneva Assessment of renal involvement Ass. Prof. M. Lyubomirova Assessment of the conitive function Ass. Prof. M. Raycheva Assessment of the the retinal vessels Prof. Petkova Dynamic assessment of the target organ damage in treated hypertension Prof. I. Gruev
18:00-18:30	Novartis symposium ARNI – a key step in the optimization of the management of HF and of the EF Prof. D. Raev
18:30-19:30	Berlin – Chemie symposium Hypertension and hyperuricemia – which of them is first? Moderator: Ass. Prof. St. Naydenov Hypertension and renal damage Dr. M. Hristova Systemic effects of the elevated uric acid levels Dr. K. Kraev
19:30 – 20:30	Session: Nessun dorma Moderators: – Prof. K. Kostov, Ass. Prof. V. Velchev Changes in the quality and duration of sleep and their relationship with the cardio-metabolic risk Dr. P. Chipev Expect the unexpected – does what we breathe affect the vascular risk? Dr. A. Simidchiev	Session: Non-pharmacological preventive methods Moderators: – Prof. Tisheva, Ass. Prof. Marchev Which diet works best for vascular prevention Ass. Prof. Popova Debate – Lifestyle Lifestyle changes work in patients with arterial hypertension Dr. Е. Goshev Lifestyle changes do not work in most patients with arterial hypertension Prof. А.Postagyan
20:30	Cocktail

Saturday, 01.02.2020

15:30 – 16:30 Educational module “Assessment of the arterial function – a practical application“

(a module organized by the Bulgarian Hypertension League)

Prof. I. Gruev, Prof. А. Postagyan

Hour	Hall A	Hall B
08:00 – 09:30	Session: Knowledge, treatment and control of arterial hypertension in Bulgaria – data from May Measurement Month 2019 Discussion panel: – Prof.А.Postagyan, Prof. D. Raev, Prof. F. Nikolov, Prof, Sn. Tisheva, Prof. Y.Yotov Knowledge, treatment and control Concomitant risk factors and diseases Average measurement values Ttreatment, drugs, and target levels What data do we have from previous initiatives of the BHL Arterial hypertension and organ damage among patients with resistant hypertension Prof. I. Petrov	Session: Perioperative evaluation and management in non-cardiac surgical interventions and accompanying arterial hypertension Moderators: Prof. I. Daskalov, Prof. M. Milanova Pre-operative evaluation of cardiovascular risk in patients with arterial hypertension Prof. I. Daskalov Antihypertensive therapy in case of impeding non-cardiac surgery, in patients with known arterial hypertension Prof. M.Milanova New onset hypertension in the perioperative period Ass. Prof. L. Demirevska Hypertensive crises in the perioperative period Dr. N. Ramshev
09:30 – 10:15	Pfizer Upjohn CV symposium The role of Adherence in CV reduction: Reflection on ESC / ESH Hypertension Guidelines Prof. D. Lovich Target organ damage and cardiovascular complications in hypertensive patients and blood pressure variability Prof. Y. Yotov
10:15 – 10:30	Coffee pause
10:30 – 11:30	Session: European Society of Hypertension Moderators: Prof. Mancia, Prof. Postagyan Prognosis and complications of hypertension Prof. D. Lovich Combination treatment in hypertension – the dos and don’ts Prof. G. Mancia
11:30 – 12:30	Actavis symposium: Arterial hypertension and chronic kidney disese Moderator: Prof. B. Bogov Recommendations for the treatment of arterial hypertension and chronic kidney disease Prof.А. Postagyan Arterial hypertension in endstage chronic kidney disease Prof. B. Bogov
12:30 – 14:00	Session: Contemporar assessment of arterial function ISVH (International Society of Vascular Health) session Moderators: Prof. Topouchian, Prof. Postagyan Methods for arterial evaluation Prof. Roland Asmar Clinical application of arterial stiffness in hypertension Prof. Nebojsa Tasic Antihypertensive treatment and arterial stiffness Prof. Harry Struijker Boudier Local and regional arterial stiffness effect of the therapy Prof. Tz. Katova	Session: Diabetes mellitus (supported by Astra Zeneca) Moderators: Prof. Yotov, Ass. Prof. Naydenov Mechanisms of cardiac and vascular protection of SGLT 2 inhibitors and GLP1 in patients with arterial hypertension and diabetes mellitus Dr. G. Grozeva Diabetic nephropathy Prof. R. Robeva Diabetic cardiomyopathy Ass. Prof. Pl. Popivanov
14:00-15:30	Session: Concept of vascular ageing (with the support of Gedeon Richter) Moderators: Acad. Ovcharov, Acad. Traykov Determinants of early vascular ageing – anatomical considerations Acad. Vl. Ovcharov Is it possible to determinate normal brain ageing Acad. L. Traykov Is it possible to determinate normal renal ageing Prof. B. Bogov Are there individuals protected from vascular damage Prof. А. Postagyan	Session: Endocrine hypertension Moderators: Prof. Zaharieva, Ass. Prof. Elenkova Arterial hypertension in Cushing syndrome Prof. S. Zaharieva Primary aldosteronism – the most common type of symptomatic hypertension Dr. Y. Matrozova Rare forms of mineralcorticoid hypertension Ass. Prof. At. Elenkova Arterial hypertension in congenital adrenal hyperplasia Dr. R. Robeva
15:30 – 15:45	Coffee pause
15:45 – 16:15	Amgen symposium Causality of elevated LDL-C levels in atherosclerotic cardiac vascular events The lower LDL-C levels are the best Prof. А. Postagyan What is the role of LDL-C in patients with cerebroVD Acad. L. Traykov
16:15 – 17:45	Session: Application of new non-invasive imaging methods for evaluating patients with AH /joint session: BHL and Bulgaian Noninvasive Imaging Association/ Moderators: Ass. Prof. Hristova, Prof. Postagyan Contemporary technics for EchoCG assessment of patients with AH Ass. Prof. K. Hristova Hypertensive CMP – contemporary EchoCM methods for assessment of ventricular remodeling Prof. Е. Kinova Assessment of LA in patients with AH Prof. N. Zlatareva Noninvasive assessment of organ damage outside the heart Dr. Sv. Tzonev Left ventricular muscle mass – how can we favorably influence it in arterial hypertension Prof. А. Postagyan.	Session: From target organ damage to clinically visible disease, focus on the coronary artery disease Moderators: Ass. Prof. Velchev, Prof. Tisheva Coronary calcium score – noninvasive screening for coronary atherosclerosis in asymptomatic subjects Ass. Prof. Angelov Does imaging help us in the choice and intensity of lipid-modulating therapy? Prof. А. Postagyan What are our requirements for optimal medical therapy in the light of modern interventional studies Ass. Prof. V. Velchev The route of patients after myocardial infarction – open questions with efocus on DAPT Dr. N. Stoyanov
17:45 – 18:30	Pfizer symposium: Rare Disease Tranthyretin amyloid cardiomiopathy – challenges and management in patients with HFpEF – CHAD-STOP! Prof. A.Postagyan Role of nuclear medicine – multimodal imaging diagnostics in patients with cardiac amyloidosis Prof. M. Garcheva
18:30 – 19:10	Sandoz symposium: Valsartan – in the heart of cardioprotection Ass. Prof. St. Naydenov
19:10 – 20:10	Session: Debate session: – Family wars Moderators: Dr. Goshev, Prof. Tisheva Type 1 diabetes mellitus – when to initiate cardiovascular protection? Prof. Y. Yotova/Prof. V. Yotov Can we change habbits? Ass. Prof. К. Postagyan/Prof. А. Postagyan

Sunday, 02.02.2020

10:00 – 11:00 Educational module “Assessment of 24hour Central Blood Pressure Parameters”

(organized by International Society of Vascular Health)

Prof. Jirar Topouchian

Hour	Hall A	Hall B
08:00 – 10:00	Session: Emergent and urgent condition in hypertensiology Moderators: Dr. Stoyanovski, Prof. Milanova Clinical spectrum of emergency conditions in hypertensiology Dr. V. Stoyanovski Therapeutic challenges in the treatment of emergent hypertensive conditions – pharmacological considerations Prof. G Momekov Therapeutic challenges of the acute aortic syndrome Ass. Prof. R. Ivanova Blood pressure dynamics in revascularised patients with ischemic stroke Ass. Prof. R. Kalpachki Arterial hypertension and stroke – therapeutic goals and time frames Dr. T. Yaneva	Session: Residual risk in arterial hypertension Moderators: Prof. Gruev, Ass. Prof. Vladimirova-Kitova Uric acid and heart risk Prof. Iv. Gruev Microbiome and hypertension Ass. Prof. S. Marchev Features of collagen and elastin metabolism in prehypertension and initial hypertension Prof. Sn. Tisheva Beyond the LDL target in concomitant dyslipidaemia Ass. Prof. Vladimirova-Kitova
10:00 – 10:40	Bayer symposium *Patients with AF, renal impairment or diabetes –* how to ensure optimal anticoagulant protection? Ass. Prof. St. Naydenov
10:40 – 11:00	Coffee pause
11:00 – 13:00	Session: Resistant hypertension – Potential predictors of the response to interventional treatment Moderators: Prof. Postagyan, Prof Gatzov Resistant hypertension – have we used all the drug options before renal denervation Prof. D. Raev Potential predictors of renal denervation response in resistant arterial hypertension BP variability Dr. S. Tochev Procedural aspects optimization Prof. I. Petrov, Dr. I. Garvanski Patient preferrences Prof. Pl. Gatzov Renal sympathetic denervation – from great expectation to present reality and back Prof. K. Tsioufis	Session: Arterial hypertension in specific groups and problems (supported by Astelas) Moderators: Ass. Prof. Naydenov, Dr. Stoyanovski Children and adolescents Ass. Prof. L. Marinov Pregnancy Ass.Prof. St. Naydenov Erectile disfunction Dr. G. Tzigarovski Antihypertensive drugs and risc of malignancy TBD
13:00 – 13:30	Valentis symposium New aspects and contemporary recommendations for the management of dyslipidemias Prof. А.Postagyan
13:30 – 14:00	Boehringer symposium Dynamics *of atrial fibrillation –* a decada of challenges and opportunities** Prof. . А. Postagyan What were the changes in the therapeutic approaches to AF, contemporary clinical changes Prof. А .Postagyan Diagnostic algorythm in embolic stroke with unclear genesis Prof.I. Staykov
14:00 – 16:00	Session: From target organ damage to clinically manifestated disease – focus on atrial fibrillation Moderators: Prof. E. Trendafilova, Prof. Gruev Screening for atrial fibrilation in Bulgaria – data from МММ 2019 Diagnostic algorythm in embolic insult with unclear genesis Dr. Kisheva Atrial fibrilation and chronic kidney disease Dr. A. Nikolaeva Choice of antithrombotic therapy in intermediate risk Prof. E. Trendafilova Demistification of HF with preserved ejection fraction – when, why, and what type of invasive treatment Dr. S. Kalustyan	Session: Original developments Moderators: Prof. Yotov, Prof. Tisheva Hypertension during pregnancy and heart function Dr. D. Gencheva, Prof. F. Nikolov Effectсiveness of renal denervation in patients with resistant hypertension – one year follow-up Dr. S. Tochev, Ass. Prof. Velchev, Dr. Rifai, Prof. Postagyan, Ass. Prof. B. Finkov Familial hypercholesterolemia and arterial hypertension in the assessment of cardiovascular risk. Dr. Y. Mladenova, Prof. Sn. Tisheva The different face of heart failure Dr. M. Rushid, Dr. L. Mircheva, Prof. Y. Yotov Arterial hypertension and atrial fibrilation Dr. D. Nikolaeva, Prof. А. Postagyan
16:00	Closing remarks

Българска Лига по Хипертония

Symposia: ARTERIALE 2020 – the circle from target organ damage to clinical event

За БЛХ

Полезни връзки

Контакти